Contact
Contact us If you have any questions or require further information, please contact us. Substipharm Paris 24 rue Erlanger75016 ParisFrance +33 (0) 1 43 18 13 00 London 5 Merchant SquareLondon W2 1AYUnited Kingdom Vygoris.com Milan Corso Europa,15,20122 Milano MI,Italycustomer-italy@substipharm.com Taipei 14F-3, N°57, Fuxing N. Rd.,Songshan Dist.,Taipei 10595 – Taiwan jshih@substipharm.com Substipharm Biologics Geneva Lancy Pont […]
Careers
Careers Substipharm has always remained deeply committed to actively involve its employees at every stage of its growth and development. Consequently, the whole team has been involved in the thinking and building of the “Substipharm 2025” company project. This allowed us to plan the company’s roadmap for the next 4 years by identifying 5 major […]
Group
About us Our success story since 1995 Since its inception, the company has evolved into a robust international group, providing medicines to an ever-increasing number of patients across the globe. It started in 1995 when we first established ourselves as pioneers in the French pharmaceutical market, thanks to our expertise in developing dossiers. In 2006, Substipharm made a major […]
ZZZ – ARCHIVE – [DEPARTEMENT] R&D
Research & Development Research & Development Our experienced R&D team handles all development steps from early stage formulation to manufacturing process validation. Our field of application is wide: generics, prescription brands, OTC, food supplements, of any kind of administration forms. We are duly aware of development dynamics and thus are committed to timelines adherence. SUBSTIPHARM’s […]
Biologics / Vaccines
Biologics / Vaccines IMOJEV®, Vaccine to protect people from Japanese Encephalitis (JE) The recent acquisition in 2022 of IMOJEV® vaccine is a significant step for Substipharm into the prevention area, making Substipharm Biologics an important healthcare player with focus in the Asia-Pacific region. This acquisition includes a local manufacturing facility exclusively dedicated to vaccines and […]
Pharmaceuticals : Generics & Specialties
Pharmaceuticals / Generics & Specialties Our expanding pharmaceutical expertise Substipharm is committed to the well-being of patients globally by delivering high-quality medicines across various therapeutic areas. Within our Pharmaceutical Division, our large portfolio of more than 90 different molecules consists of mature brands, niche generics, difficult-to-develop medicines, and value-added presentations. We commercialize them either directly or through licensing […]
ZZZ – ARCHIVE – EDITO2
EDITO Company history 1995-2021 1995 1995 Etablished 2006 2006 Supply Pharmaceutical Products 2010 2010 International Sales 2013 2013 €50m Sales Milestone 2016 2016 London office 2017 2017 Mitem™ Acquisition 2018 2018 Nystan™ Acquisition 2019 2019 Evista™ Acquisition 2020 2020 Milan portfolio acquisition 2021 2021 Gerda Labs Acquisition 2021 2021 Milan Office 2021 2021 €160m Sales […]
ZZZ – ARCHIVE – EDITO1
EDITO Offres d’emplois Titre du post description courte, lorem ipsum dolor sit amet. En savoir plus Titre du post description courte, lorem ipsum dolor sit amet. En savoir plus Titre du post description courte, lorem ipsum dolor sit amet. En savoir plus Titre du post description courte, lorem ipsum dolor sit amet. En savoir plus […]
ZZZ – ARCHIVE – Activity
Activity Pharmaceuticals & generics and specialilties Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos […]
ZZZ – ARCHIVE – Accueil V2 vidéo non mix
Pharmaceuticals and Biologics to treat everyone in the world Our mission is to provide niche or mature medications and vaccins of quality by direct or indirect business through a human company size Contact us Multi-activity laboratories we are a long-term partner for trusted healthcare solutions that serve patients all around the world. Pharmaceuticals / generics […]
